Sanders, C V <br/><br/>
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.  [electronic resource] 

 -  Intensive care medicine  Jul 1994 
 - S21-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0342-4642 
<br/><br/><label>Standard No.: </label>10.1007/BF01745247  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amikacin--adverse effects<br/>Community-Acquired Infections--drug therapy<br/>Cross Infection--drug therapy<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Penicillanic Acid--adverse effects<br/>Piperacillin--adverse effects<br/>Respiratory Tract Infections--drug therapy<br/>Tazobactam<br/>beta-Lactamase Inhibitors